Iomeron (Iomeprol)

Iomeron, an iodinated contrast agent, is employed to enhance X‑ray based imaging across several clinical applications.

• Vascular imaging (angiography): improves delineation of blood vessels and vascular pathology.
• Arthrography: enhances joint space visualization for diagnostic assessment.
• Myelography: provides clear contrast of the spinal canal and nerve roots.
• General radiographic procedures: increases soft‑tissue contrast in CT and fluoroscopic studies.

• Iomeprol contains a high concentration of iodine atoms that strongly absorb X‑ray photons. When injected into the vascular or body compartments, the iodine atoms increase the radiodensity of the surrounding tissues, creating a marked difference between enhanced and non‑enhanced structures on radiographic images. This attenuation of X‑rays allows clinicians to visualize anatomical details that would otherwise be indistinct.

Iomeron may be associated with a range of adverse reactions, varying from mild and transient to severe and potentially life‑threatening.

Common Side Effects

• Warmth or flushing sensation
• Metallic taste
• Mild nausea or vomiting
• Headache
• Transient urticaria or itching
• Injection site pain or discomfort

Serious or Rare Side Effects

• Anaphylactic or severe allergic reaction
• Acute kidney injury or renal impairment
• Thyroid dysfunction (hyper‑ or hypothyroidism)
• Seizures or neurological events
• Cardiac arrhythmias
• Pulmonary edema or respiratory distress

Prior to administering Iomeron, clinicians should observe specific precautions to minimize risk and ensure patient safety.

• Assess renal function: evaluate serum creatinine and eGFR before use.
• Review allergy history: identify prior reactions to iodinated contrast or related agents.
• Use lowest effective dose: tailor volume to the specific imaging study.
• Monitor thyroid status: consider in patients with known thyroid disease.
• Avoid in patients with documented severe hypersensitivity to iodinated contrast media.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with other medicines, influencing safety or efficacy; awareness of major and moderate interactions guides clinical decisions.

Major Interactions (Avoid)

• Concurrent administration of other iodinated contrast agents.
• Nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs) in patients with impaired renal function.
• Thyroid hormone therapy in uncontrolled hyperthyroidism.
• Radiopharmaceuticals containing iodine that may alter diagnostic accuracy.
• Metformin in patients with reduced renal clearance (risk of lactic acidosis).

Moderate Interactions (Monitor Closely)

• Loop diuretics: may affect fluid balance and contrast elimination.
• ACE inhibitors or ARBs: can potentiate renal effects of contrast.
• Calcium channel blockers: monitor blood pressure changes.
• Beta‑blockers: observe for altered hemodynamic response.
• Anticoagulants: increased bleeding risk with intrathecal administration.